📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Renalytix

1.1 - Company Overview

Renalytix Logo

Renalytix

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of AI-enabled clinical diagnostic solutions for kidney disease, improving risk assessment, clinical care, and patient stratification. Offers KidneyIntelX, a platform to assess risk of progressive decline in diabetic kidney disease; KidneyIntelX.dkd, an FDA-authorized test predicting risk in adults with type 2 diabetes and early-stage chronic kidney disease; and Well Filtered insights via blog, webinar, and podcast series.

Products and services

  • KidneyIntelX.dkd: An FDA-authorized test that predicts risk of kidney function decline in adults with type 2 diabetes and early-stage chronic kidney disease
  • KidneyIntelX: An AI-enabled diagnostic platform that helps clinical teams assess risk of progressive decline in kidney function in patients with diabetic kidney disease
  • Well Filtered: A multi-format blog, webinar, and podcast series that delivers insights and innovations in kidney health

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Renalytix

NaphCare Logo

NaphCare

HQ: United States Website
  • Description: Provider of correctional healthcare services and technology, offering a proactive care model, TechCare EHR and medical operations platform, STATCare 24/7 telehealth, Medication Assisted Treatment programs, Behavioral Health Units, and NaphCare Rx in-house pharmacy to improve inmate health, ensure compliance, and reduce costs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NaphCare company profile →
CodaMetrix Logo

CodaMetrix

HQ: United States Website
  • Description: Provider of an AI-powered autonomous medical coding platform for healthcare revenue cycle management, translating clinical notes into billing and diagnostic codes without human intervention. Offers a cloud-based solution for patient care and revenue cycle management and CMX Amplify, a coding decision support tool embedded in EHR systems to assist coders with complex cases, improving efficiency and accuracy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CodaMetrix company profile →
NeuronUP Logo

NeuronUP

HQ: Spain Website
  • Description: Provider of a platform supporting professionals involved in cognitive rehabilitation and stimulation processes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NeuronUP company profile →
LifeMasters Logo

LifeMasters

HQ: United States Website
  • Description: Provider of disease management programs and services that create health and foster partnerships among individuals, their physicians, and payors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LifeMasters company profile →
TransChart Logo

TransChart

HQ: United States Website
  • Description: Provider of transplant support for kidney, heart, lung, liver, pancreas (Islet Cell), and small bowel.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TransChart company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Renalytix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Renalytix

2.2 - Growth funds investing in similar companies to Renalytix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Renalytix

4.2 - Public trading comparable groups for Renalytix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Renalytix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Renalytix

What does Renalytix do?

Renalytix is a provider of AI-enabled clinical diagnostic solutions for kidney disease, improving risk assessment, clinical care, and patient stratification. Offers KidneyIntelX, a platform to assess risk of progressive decline in diabetic kidney disease; KidneyIntelX.dkd, an FDA-authorized test predicting risk in adults with type 2 diabetes and early-stage chronic kidney disease; and Well Filtered insights via blog, webinar, and podcast series.

Who are Renalytix's competitors?

Renalytix's competitors and similar companies include NaphCare, CodaMetrix, NeuronUP, LifeMasters, and TransChart.

Where is Renalytix headquartered?

Renalytix is headquartered in United Kingdom.

How many employees does Renalytix have?

Renalytix has 1,000 employees 🔒.

When was Renalytix founded?

Renalytix was founded in 2010 🔒.

What sector and industry vertical is Renalytix in?

Renalytix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Renalytix

Who are the top strategic acquirers in Renalytix's sector and industry

Top strategic M&A buyers and acquirers in Renalytix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Renalytix?

Top strategic M&A buyers groups and sectors for Renalytix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Renalytix's sector and industry vertical

Which are the top PE firms investing in Renalytix's sector and industry vertical?

Top PE firms investing in Renalytix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Renalytix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Renalytix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Renalytix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Renalytix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Renalytix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Renalytix?

The key public trading comparables and valuation benchmarks for Renalytix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Renalytix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Renalytix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Renalytix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Renalytix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Renalytix's' sector and industry vertical?

Access recent funding rounds and capital raises in Renalytix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Renalytix

Launch login modal Launch register modal